Burberry Group PLC
03 December 2003
Burberry Group plc ('the Company')
As potential beneficiaries of the holdings of The Burberry Group plc ESOP Trust
('the Trust'), employees of the Company and its subsidiaries and the following
directors of the Company; Rose Marie Bravo, Thomas J. O'Neill and Michael
Metcalf are deemed, under section 324 Companies Act 1985, to have an interest in
the Ordinary Shares of 0.05p each in the Company ('Shares') held by the Trust.
John Peace and David Tyler, non-executive directors of the Company and the
employees of the GUS group, the majority shareholder of Burberry Group plc, are
also potential beneficiaries of the holdings of the Trust. Accordingly, they are
also deemed, under section 324 Companies Act 1985, to have an interest in the
Shares held by the Trust.
The Company received notification on 2 December 2003, from Abacus Corporate
Trustee Limited as trustee of the Trust and on behalf of the directors named
above that, on 1 December 2003, it had sold 12,400 Shares at a price of £3.87
per Share.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.